Autres langues Amgen Inc. Sao Paulo

Actions

AMGN34

BRAMGNBDR004

Produits pharmaceutiques

Marché Fermé - Sao Paulo 21:38:32 21/08/2026			Varia. 5j.	Varia. 1 janv.
80,70 ^BRL	+5,14%		+4,20%	+22,35%

20/08	Amgen Inc. : Piper Sandler optimiste sur le dossier	ZM
19/08	Amgen Inc. : Argus réitère son opinion positive sur le titre	ZM

Autres langues

21/08	FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case
18/08	GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
18/08	CSL's Share Price Hits Six-Month High on Guidance Beat
17/08	Sandoz: diritti commerciali su alcuni biosimilari cinesi
17/08	Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech
14/08	Amgen Insider Sold Shares Worth $1,346,499, According to a Recent SEC Filing
11/08	Global drugmakers invest billions to boost US presence
10/08	Amgen Insider Sold Shares Worth $1,194,416, According to a Recent SEC Filing
10/08	Amgen Insider Sold Shares Worth $1,565,898, According to a Recent SEC Filing
06/08	Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
05/08	Aktien New York Schluss: Dow setzt Rekordjagd dank Iran-Hoffnungen fort
05/08	Dow closes at record on Mideast optimism; SpaceX, AMD drag Nasdaq
05/08	Mideast deal hopes lift Dow, S&P to records; SpaceX, AMD drag Nasdaq
05/08	Aktien New York: Iran-Hoffnungen sorgen für Rekorde bei Dow und S&P 500
05/08	Analyst recommendations: Palantir Technologies, McDonald's, Booking Holdings, Arista Networks, Amgen...
05/08	Amgen handily beats consensus in Q2
05/08	Amgen wird erneut etwas optimistischer - Anleger hoch erfreut
05/08	Food And Drug Authority Approves Neulasta Under BLA 125031
04/08	Amgen Lifts Outlook on Strong 2Q Drug Sales, to End Early Development of Obesity Treatment
04/08	Amgen Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance
04/08	Amgen: Q2 Earnings Snapshot
04/08	(AMGN) Amgen Expects Full Year 2026 Revenue Range $38.2B - $39.4B, vs. FactSet Est of $37.74B
04/08	(AMGN) Amgen Expects Full Year 2026 Adjusted EPS Range $22.30 - $23.50, vs. FactSet Est of $22.36
04/08	Amgen second-quarter sales rise 9%, profit tops Street view
04/08	Earnings Flash (AMGN) Amgen Inc. Posts Q2 Adjusted EPS $6.29 per Share, vs. FactSet Est of $5.62